Loading…
Contribution of tryptophan and its metabolites to transplant outcome: a mini-review
Long-term tolerance in the absence of immunosuppressive drugs is a major goal in the transplantation field, not yet attained. Recent research on the role of commensal microbiota in the control of immunity has opened new avenues for the search of novel clinical interventions. Indeed, products of inte...
Saved in:
Published in: | Frontiers in immunology 2024-10, Vol.15, p.1395421 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c306t-dda8b187a4a57810396c270ac8a1ecc612f353078b17974f689d511e2f1b95db3 |
container_end_page | |
container_issue | |
container_start_page | 1395421 |
container_title | Frontiers in immunology |
container_volume | 15 |
creator | Donoso-Meneses, Darío Padilla, Cristina Moya-Guzmán, María José Alegre, Maria-Luisa Pino-Lagos, Karina |
description | Long-term tolerance in the absence of immunosuppressive drugs is a major goal in the transplantation field, not yet attained. Recent research on the role of commensal microbiota in the control of immunity has opened new avenues for the search of novel clinical interventions. Indeed, products of intestinal metabolism generated by both host cells and the microbiota have been identified as modulators of the immune response. Among these, tryptophan (Trp) and its derivatives are being investigated to understand their impact on alloimmunity and their potential usefulness as therapeutic targets to improve allograft survival. Here, we reviewed the latest findings on the contribution of Trp metabolic pathways to transplant outcomes. |
doi_str_mv | 10.3389/fimmu.2024.1395421 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_80ce93ef52db4c45b333019d7b68b1b0</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_80ce93ef52db4c45b333019d7b68b1b0</doaj_id><sourcerecordid>3122633012</sourcerecordid><originalsourceid>FETCH-LOGICAL-c306t-dda8b187a4a57810396c270ac8a1ecc612f353078b17974f689d511e2f1b95db3</originalsourceid><addsrcrecordid>eNpVkUtP3DAUhS0EAgT8ARbIy24y-J24mwqNWkBC6qKwtvwKGCVxajtU_Pt6mAGBN7auz_2ufQ4A5xitKO3kZR_GcVkRRNgKU8kZwXvgGAvBGkoI2_90PgJnOT-jupiklPJDcEQlaxnD4hj8WceppGCWEuIEYw9Lep1LnJ_0BPXkYCgZjr5oE4dQfIYlVoWe8jzoqcC4FBtH_x1qOIYpNMm_BP_vFBz0esj-bLefgIdfP-_XN83d7-vb9dVdYykSpXFOdwZ3rWaatx1GVApLWqRtp7G3VmDSU05RW0WtbFkvOuk4xp702EjuDD0Bt1uui_pZzSmMOr2qqIN6K8T0qHQqwQ5edch6SX3PiTPMMm6qEQhL1xpR8QZV1o8ta17M6J311RU9fIF-vZnCk3qMLwpjXv_ASCV82xFS_Lv4XNQYsvVDNcrHJSuKCRGbqRsp2Uptijkn33_MwUht0lVv6apNumqXbm26-PzCj5b3LOl_Yy2iZg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3122633012</pqid></control><display><type>article</type><title>Contribution of tryptophan and its metabolites to transplant outcome: a mini-review</title><source>PubMed Central</source><creator>Donoso-Meneses, Darío ; Padilla, Cristina ; Moya-Guzmán, María José ; Alegre, Maria-Luisa ; Pino-Lagos, Karina</creator><creatorcontrib>Donoso-Meneses, Darío ; Padilla, Cristina ; Moya-Guzmán, María José ; Alegre, Maria-Luisa ; Pino-Lagos, Karina</creatorcontrib><description>Long-term tolerance in the absence of immunosuppressive drugs is a major goal in the transplantation field, not yet attained. Recent research on the role of commensal microbiota in the control of immunity has opened new avenues for the search of novel clinical interventions. Indeed, products of intestinal metabolism generated by both host cells and the microbiota have been identified as modulators of the immune response. Among these, tryptophan (Trp) and its derivatives are being investigated to understand their impact on alloimmunity and their potential usefulness as therapeutic targets to improve allograft survival. Here, we reviewed the latest findings on the contribution of Trp metabolic pathways to transplant outcomes.</description><identifier>ISSN: 1664-3224</identifier><identifier>EISSN: 1664-3224</identifier><identifier>DOI: 10.3389/fimmu.2024.1395421</identifier><identifier>PMID: 39474416</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>Animals ; Gastrointestinal Microbiome - immunology ; Graft Rejection - immunology ; Graft Rejection - metabolism ; Graft Survival - immunology ; Humans ; immune regulation ; Immunology ; microbiota ; Organ Transplantation ; tolerance ; transplantation ; Transplantation Tolerance ; Treatment Outcome ; trypthophan metabolism ; Tryptophan - metabolism</subject><ispartof>Frontiers in immunology, 2024-10, Vol.15, p.1395421</ispartof><rights>Copyright © 2024 Donoso-Meneses, Padilla, Moya-Guzmán, Alegre and Pino-Lagos.</rights><rights>Copyright © 2024 Donoso-Meneses, Padilla, Moya-Guzmán, Alegre and Pino-Lagos 2024 Donoso-Meneses, Padilla, Moya-Guzmán, Alegre and Pino-Lagos</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c306t-dda8b187a4a57810396c270ac8a1ecc612f353078b17974f689d511e2f1b95db3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11518742/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11518742/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39474416$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Donoso-Meneses, Darío</creatorcontrib><creatorcontrib>Padilla, Cristina</creatorcontrib><creatorcontrib>Moya-Guzmán, María José</creatorcontrib><creatorcontrib>Alegre, Maria-Luisa</creatorcontrib><creatorcontrib>Pino-Lagos, Karina</creatorcontrib><title>Contribution of tryptophan and its metabolites to transplant outcome: a mini-review</title><title>Frontiers in immunology</title><addtitle>Front Immunol</addtitle><description>Long-term tolerance in the absence of immunosuppressive drugs is a major goal in the transplantation field, not yet attained. Recent research on the role of commensal microbiota in the control of immunity has opened new avenues for the search of novel clinical interventions. Indeed, products of intestinal metabolism generated by both host cells and the microbiota have been identified as modulators of the immune response. Among these, tryptophan (Trp) and its derivatives are being investigated to understand their impact on alloimmunity and their potential usefulness as therapeutic targets to improve allograft survival. Here, we reviewed the latest findings on the contribution of Trp metabolic pathways to transplant outcomes.</description><subject>Animals</subject><subject>Gastrointestinal Microbiome - immunology</subject><subject>Graft Rejection - immunology</subject><subject>Graft Rejection - metabolism</subject><subject>Graft Survival - immunology</subject><subject>Humans</subject><subject>immune regulation</subject><subject>Immunology</subject><subject>microbiota</subject><subject>Organ Transplantation</subject><subject>tolerance</subject><subject>transplantation</subject><subject>Transplantation Tolerance</subject><subject>Treatment Outcome</subject><subject>trypthophan metabolism</subject><subject>Tryptophan - metabolism</subject><issn>1664-3224</issn><issn>1664-3224</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkUtP3DAUhS0EAgT8ARbIy24y-J24mwqNWkBC6qKwtvwKGCVxajtU_Pt6mAGBN7auz_2ufQ4A5xitKO3kZR_GcVkRRNgKU8kZwXvgGAvBGkoI2_90PgJnOT-jupiklPJDcEQlaxnD4hj8WceppGCWEuIEYw9Lep1LnJ_0BPXkYCgZjr5oE4dQfIYlVoWe8jzoqcC4FBtH_x1qOIYpNMm_BP_vFBz0esj-bLefgIdfP-_XN83d7-vb9dVdYykSpXFOdwZ3rWaatx1GVApLWqRtp7G3VmDSU05RW0WtbFkvOuk4xp702EjuDD0Bt1uui_pZzSmMOr2qqIN6K8T0qHQqwQ5edch6SX3PiTPMMm6qEQhL1xpR8QZV1o8ta17M6J311RU9fIF-vZnCk3qMLwpjXv_ASCV82xFS_Lv4XNQYsvVDNcrHJSuKCRGbqRsp2Uptijkn33_MwUht0lVv6apNumqXbm26-PzCj5b3LOl_Yy2iZg</recordid><startdate>20241015</startdate><enddate>20241015</enddate><creator>Donoso-Meneses, Darío</creator><creator>Padilla, Cristina</creator><creator>Moya-Guzmán, María José</creator><creator>Alegre, Maria-Luisa</creator><creator>Pino-Lagos, Karina</creator><general>Frontiers Media S.A</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20241015</creationdate><title>Contribution of tryptophan and its metabolites to transplant outcome: a mini-review</title><author>Donoso-Meneses, Darío ; Padilla, Cristina ; Moya-Guzmán, María José ; Alegre, Maria-Luisa ; Pino-Lagos, Karina</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c306t-dda8b187a4a57810396c270ac8a1ecc612f353078b17974f689d511e2f1b95db3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Animals</topic><topic>Gastrointestinal Microbiome - immunology</topic><topic>Graft Rejection - immunology</topic><topic>Graft Rejection - metabolism</topic><topic>Graft Survival - immunology</topic><topic>Humans</topic><topic>immune regulation</topic><topic>Immunology</topic><topic>microbiota</topic><topic>Organ Transplantation</topic><topic>tolerance</topic><topic>transplantation</topic><topic>Transplantation Tolerance</topic><topic>Treatment Outcome</topic><topic>trypthophan metabolism</topic><topic>Tryptophan - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Donoso-Meneses, Darío</creatorcontrib><creatorcontrib>Padilla, Cristina</creatorcontrib><creatorcontrib>Moya-Guzmán, María José</creatorcontrib><creatorcontrib>Alegre, Maria-Luisa</creatorcontrib><creatorcontrib>Pino-Lagos, Karina</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Donoso-Meneses, Darío</au><au>Padilla, Cristina</au><au>Moya-Guzmán, María José</au><au>Alegre, Maria-Luisa</au><au>Pino-Lagos, Karina</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Contribution of tryptophan and its metabolites to transplant outcome: a mini-review</atitle><jtitle>Frontiers in immunology</jtitle><addtitle>Front Immunol</addtitle><date>2024-10-15</date><risdate>2024</risdate><volume>15</volume><spage>1395421</spage><pages>1395421-</pages><issn>1664-3224</issn><eissn>1664-3224</eissn><abstract>Long-term tolerance in the absence of immunosuppressive drugs is a major goal in the transplantation field, not yet attained. Recent research on the role of commensal microbiota in the control of immunity has opened new avenues for the search of novel clinical interventions. Indeed, products of intestinal metabolism generated by both host cells and the microbiota have been identified as modulators of the immune response. Among these, tryptophan (Trp) and its derivatives are being investigated to understand their impact on alloimmunity and their potential usefulness as therapeutic targets to improve allograft survival. Here, we reviewed the latest findings on the contribution of Trp metabolic pathways to transplant outcomes.</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>39474416</pmid><doi>10.3389/fimmu.2024.1395421</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1664-3224 |
ispartof | Frontiers in immunology, 2024-10, Vol.15, p.1395421 |
issn | 1664-3224 1664-3224 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_80ce93ef52db4c45b333019d7b68b1b0 |
source | PubMed Central |
subjects | Animals Gastrointestinal Microbiome - immunology Graft Rejection - immunology Graft Rejection - metabolism Graft Survival - immunology Humans immune regulation Immunology microbiota Organ Transplantation tolerance transplantation Transplantation Tolerance Treatment Outcome trypthophan metabolism Tryptophan - metabolism |
title | Contribution of tryptophan and its metabolites to transplant outcome: a mini-review |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T22%3A03%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Contribution%20of%20tryptophan%20and%20its%20metabolites%20to%20transplant%20outcome:%20a%20mini-review&rft.jtitle=Frontiers%20in%20immunology&rft.au=Donoso-Meneses,%20Dar%C3%ADo&rft.date=2024-10-15&rft.volume=15&rft.spage=1395421&rft.pages=1395421-&rft.issn=1664-3224&rft.eissn=1664-3224&rft_id=info:doi/10.3389/fimmu.2024.1395421&rft_dat=%3Cproquest_doaj_%3E3122633012%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c306t-dda8b187a4a57810396c270ac8a1ecc612f353078b17974f689d511e2f1b95db3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3122633012&rft_id=info:pmid/39474416&rfr_iscdi=true |